Company / Current Liabilities
AGIOS PHARMACEUTICALS, INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$82.2M
FY2025
5-year range
$59.8M / $82.2M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#114 of 213
Health Care
What the data says
At $82M, AGIOS PHARMACEUTICALS, INC.'s current liabilities ranks #100 of 213 in the Health Care sector. Current Liabilities has increased for 4 consecutive years, from $60M in FY2021 to $82M in FY2025.
Based on SEC 10-K filings.
$82M in FY2025 with a 5-year CAGR of -2.7%.
Increased from $68M to $82M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
#100 of 213 in Health CareTop 46% of 213This company $82.2M Sector average $1.6B
▼
-94.8% below sector average
Key checks
Key Insights
- AGIOS PHARMACEUTICALS, INC.'s current liabilities has grown for 4 consecutive years.
- 5-year CAGR of -2.7%, indicating a declining trend.
- In FY2025, current liabilities increased 1.3% year-over-year.
- Ranks #114 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.2M | +1.3% |
| FY2024 | $81.2M | +19.4% |
| FY2023 | $68.0M | +8.5% |
| FY2022 | $62.6M | +4.7% |
| FY2021 | $59.8M | -36.6% |
| FY2020 | $94.4M | +1.6% |
| FY2019 | $92.9M | -0.7% |
| FY2018 | $93.5M | -1.5% |
| FY2017 | $94.9M | +7.4% |
| FY2016 | $88.4M | +67.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026